Intellectual Property India Publishes Patent Application for A Targeted Lentiviral Delivery System For In Vivo Car T Cell Therapy, And A Method For The Same

MUMBAI, India, Nov. 6 -- Intellectual Property India has published a patent application (202511034051 A) filed by Ruquaiya Alam; and Tanveer Ahmad on April 07, 2025, for A Targeted Lentiviral Delivery System For In Vivo Car T Cell Therapy, And A Method For The Same.

Inventors include Ruquaiya Alam; and Tanveer Ahmad.

The application for the patent was published on November 06, 2026, under issue no. 45/2026.

Abstract: The present invention relates to a high-specificity targeted lentiviral delivery system for in vivo CAR T-cell therapy, engineered to eliminate pseudo-transduction of off- target cells. The system utilizes an engineered producer cell line that expresses T-cell engaging ligands (CD3 scFv, CD80, and CD252) and a mutated, serum...